G1359A Polymorphism in the Cannabinoid Receptor-1 Gene Is Associated with Metabolic Syndrome in the Chinese Han Population

This publication has 33 references indexed in Scilit:

• Differential alterations of the concentrations of endocannabinoids and related lipids in the subcutaneous adipose tissue of obese diabetic patients
  Lipids in Health and Disease, 2010
• Metabolic Syndrome: An Evolving Threat in the Genesis of Coronary Artery Disease
  Journal of the CardioMetabolic Syndrome, 2007
• Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
  International Journal of Obesity, 2007
• Dysregulation of the Peripheral and Adipose Tissue Endocannabinoid System in Human Abdominal Obesity
  Diabetes, 2006
• Genetic determinants of the metabolic syndrome
  Nature Clinical Practice Cardiovascular Medicine, 2006
• Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients
  JAMA, 2006
• The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
  Endocrine Reviews, 2005
• Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
  The Lancet, 2005
• CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity
  International Journal of Obesity, 2004
• The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis
  Journal of Clinical Investigation, 2003